Shelley Nolan

About Shelley Nolan

Three time national award winning sales professional with a long record of delivering double-digit market share gains in highly competitive biopharm market. Proven leader in the medical sales industry with superior communication and interpersonal skills as well as a solid record of exceeding sales expectations and quotas. Excels in areas of relationship selling with a deep understanding of territory strategy, management and execution. Known for scientific knowledge of products, analytical skills, confidence to sell against the toughest competitors with ability to think and act quickly and decisively.

Experience

1. Account Manager

   Novo Nordisk

   Jan 2009 — Present

   Health SystemsDiabetes Care Specialist II Novo Nordisk Inc. 2009-PresentSuccessfully managing 120 accounts across 3-state area comprising 300+ professionals ranging from C-suite executives to specialty physicians and CDE’s to MA’s. Prioritize call plan to include high volume providers, offering device training, product education and resource allocation on 4 prescription injectable medications for Diabetes Mellitus. Sales AchievementsCircle Of Excellence Award Winner-105% to goal for IC attainment: 173% attainment for top product -(2011) Highest award offered by NNI (documentation available)Area Achievement Award-finished in top 12% with 101.8% attainment -2013 (documentation available)New Hire Recognition-finished 2nd in class of 127 for selling and presentation skillsPromoted twice in tenure: from Diabetes Care Specialist to HS DCS I to HSDCS II: promotion included addition of calling on institutions as well as retail salesEarned overall rating of “Exceeds Expections” on year-end sales review for past four years 20••••13 IC above 100%(documentation available)Continually noted for “exceptional collaboration across business channels” Doubled: Levemir MS from 12.0% to 23% retail and 25.6% to 54.8% in HospitalsTripled: Victoza MS from 0.0% to 12.2% in increasingly crowded NIAD marketDouble Digit: Novolog MS growth even with declining formulary access 46.8% to 55.1% retail and 35.7% to 50.0% in Hospitals

Education

• University of Minnesota

  Journalism, Speech Communication and Rhetoric

  1994 — 1999